Laura Blanco-Fernández

5PUBLICATIONS

51CO-AUTHORS

Haematological tumoursGene and molecular therapyCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 17, 2026

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

|Oct 30, 2024

Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma.

Jan Eckmann, Tanja Fauti, Marlene Biehl

|Aug 06, 2024

Inhibition of MICA and MICB shedding enhances memory-like NK-cell-mediated cytotoxicity against multiple myeloma.

Sabrin Tahri, Sara Piccinelli, Nang Kham Su

|May 30, 2024

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Esperanza Martín-Sánchez, Laura Blanco, Peter S Kim

|Dec 19, 2018

A Gemini Cationic Lipid with Histidine Residues as a Novel Lipid-Based Gene Nanocarrier: A Biophysical and Biochemical Study.

María Martínez-Negro, Laura Blanco-Fernández, Paolo M Tentori

Pageof 1

Frequent Collaborators

3 joint publications

Bruno Paiva

2 joint publications

Felipe Prosper

2 joint publications

Aintzane Zabaleta Azpiroz

2 joint publications

Thomas Kraft

1 joint publications

Esperanza Martín-Sánchez

Hongfang Wang

Jesus F San Miguel

Ana Alfonso

Juan Bergua

Rebeca Rodríguez-Veiga

Frequent Collaborators

3 joint publications

Bruno Paiva

2 joint publications

Felipe Prosper

2 joint publications

Aintzane Zabaleta Azpiroz

2 joint publications

Thomas Kraft